Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 509

1.

Characterization of vinpocetine effects on DA and DOPAC release in striatal isolated nerve endings.

Trejo F, Nekrassov V, Sitges M.

Brain Res. 2001 Aug 3;909(1-2):59-67.

PMID:
11478921
[PubMed - indexed for MEDLINE]
2.

Characterization of phenytoin, carbamazepine, vinpocetine and clorgyline simultaneous effects on sodium channels and catecholamine metabolism in rat striatal nerve endings.

Sitges M, Aldana BI, Chiu LM, Nekrassov V.

Neurochem Res. 2009 Mar;34(3):470-9. doi: 10.1007/s11064-008-9805-7. Epub 2008 Aug 19.

PMID:
18712476
[PubMed - indexed for MEDLINE]
3.

Single and combined effects of carbamazepine and vinpocetine on depolarization-induced changes in Na+, Ca2+ and glutamate release in hippocampal isolated nerve endings.

Sitges M, Chiu LM, Nekrassov V.

Neurochem Int. 2006 Jul;49(1):55-61. Epub 2006 Apr 18.

PMID:
16621162
[PubMed - indexed for MEDLINE]
4.

Dopamine transporter mediated release of dopamine: role of chloride.

Sitges M, Reyes A, Chiu LM.

J Neurosci Res. 1994 Sep 1;39(1):11-22.

PMID:
7807588
[PubMed - indexed for MEDLINE]
5.

Vinpocetine blockade of sodium channels inhibits the rise in sodium and calcium induced by 4-aminopyridine in synaptosomes.

Sitges M, Galván E, Nekrassov V.

Neurochem Int. 2005 Jun;46(7):533-40.

PMID:
15843047
[PubMed - indexed for MEDLINE]
6.
7.

Transmitter release by non-receptor activation of the alpha-subunit of guanine nucleotide regulatory protein in rat striatal slices.

Zelles T, Chernaeva L, Baranyi M, Déri Z, Adam-Vizi V, Vizi ES.

J Neurosci Res. 1995 Oct 1;42(2):242-51.

PMID:
8568925
[PubMed - indexed for MEDLINE]
8.

Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.

Lamensdorf I, Youdim MB, Finberg JP.

J Neurochem. 1996 Oct;67(4):1532-9.

PMID:
8858937
[PubMed - indexed for MEDLINE]
9.

Differential effect of quinpirole and 7-OH-DPAT on the spontaneous [(3)H]-dopamine efflux from rat striatal synaptosomes.

García-Sanz A, Badia A, Clos MV.

Synapse. 2001 Apr;40(1):65-73.

PMID:
11170223
[PubMed - indexed for MEDLINE]
11.

Nomifensine reveals age-related changes in K(+)-evoked striatal DA overflow in F344 rats.

Stanford JA, Currier TD, Purdom MS, Gerhardt GA.

Neurobiol Aging. 2001 May-Jun;22(3):495-502.

PMID:
11378257
[PubMed - indexed for MEDLINE]
12.

Vinpocetine selectively inhibits neurotransmitter release triggered by sodium channel activation.

Sitges M, Nekrassov V.

Neurochem Res. 1999 Dec;24(12):1585-91.

PMID:
10591410
[PubMed - indexed for MEDLINE]
13.

The neuroprotective drug vinpocetine prevents veratridine-induced [Na+]i and [Ca2+]i rise in synaptosomes.

Tretter L, Adam-Vizi V.

Neuroreport. 1998 Jun 1;9(8):1849-53.

PMID:
9665614
[PubMed - indexed for MEDLINE]
14.
15.

The in vivo modulation of dopamine synthesis by calcium ions: influences on the calcium independent release.

Olivier V, Gobert A, Guibert B, Leviel V.

Neurochem Int. 1999 Dec;35(6):431-8.

PMID:
10524710
[PubMed - indexed for MEDLINE]
16.

Carrier-mediated release of monoamines induced by the nicotinic acetylcholine receptor agonist DMPP.

Szász BK, Mayer A, Zsilla G, Lendvai B, Vizi ES, Kiss JP.

Neuropharmacology. 2005 Sep;49(3):400-9.

PMID:
15993437
[PubMed - indexed for MEDLINE]
17.
18.
20.

Effects of verapamil on the release of different neurotransmitters.

Sitges M, Reyes A.

J Neurosci Res. 1995 Apr 1;40(5):613-21.

PMID:
7602614
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk